UK establishes AI biosafety lab supported by OpenAI and Anthropic – Unite.AI

The UK Government is establishing the AI ​​Biosecurity Lab, supported by £100m of government funding and up to £200m in corporate commitments from OpenAI and Anthropic, the Cabinet Office announced on 24 October 2026.

The announcement states that advances in artificial intelligence are creating unprecedented opportunities for scientific discovery, but are also changing the biorisk landscape. AI can accelerate research, improve understanding of diseases, and support the discovery and development of new medical countermeasures, while increasingly capable AI systems also create new biological risks and could lower barriers against malicious activity.

The government described AIBL as the world’s first organization dedicated to AI biosafety and said the lab builds on the UK’s broader biosafety strategy. The overall package behind the lab included up to £300m of government funding and corporate commitments.

Mission and initial delivery

According to the announcement, the lab’s mission will be to strengthen biosecurity by leveraging frontier artificial intelligence. It will bring together frontier AI and life science talent to develop practical technical capabilities that improve the UK’s ability to understand, prevent, detect and respond to biological threats, and the Government has said its research will strengthen the UK’s and the world’s resilience to a wide range of biological risks, including those enabled by advances in artificial intelligence.

The initial delivery will focus on the development and deployment of capabilities that improve the early detection of emerging biological threats and accelerate the development of vaccines, treatments and other medical countermeasures. The Government said AIBL will harness frontier AI to support partners including the UK’s national biosafety centers and the country’s life sciences industry, enabling the UK and the world to respond more quickly to outbreaks and strengthening resilience against future biological risks.

Corporate commitments and research partnerships

The announcement states that AIBL will launch with a commitment of up to £200 million from two frontier AI companies. OpenAI will provide £100 million in compute and model credits, along with reliable access to its most capable models through its Rosalind Biodefense programme. Anthropic will provide up to £100 million in model credits, access to trusted models and dedicated technical support.

According to the announcement, AIBL will also collaborate with Google DeepMind and Basecamp Research on research and artificial intelligence collaborations for scientific instruments. Google DeepMind scientists and biosafety experts will work with the lab and seek to provide reliable access to frontier Gemini and specialized science models. Basecamp Research, described in the announcement as a pioneering UK AI life sciences company, will provide access to its AI biology models, capabilities and technical expertise to address priority biosecurity challenges.

The government has said partnerships will be key to AIBL’s approach. The lab will work with public sector organisations, academic institutions, industry partners and frontier AI companies in the UK and internationally, and the Government intends for it to be supported by both public and philanthropic funding so that further investment can be channeled towards strengthening biosafety capabilities over time.

OpenAI launched Rosalind Biodefense on May 29, 2026, as a program to sponsor trusted developers building defensive applications of artificial intelligence in the life sciences using GPT-Rosalind, the company’s frontier reasoning model for life sciences research. OpenAI said at the time that the program supports work in areas such as epidemiological modeling, early detection, screening, preparedness and non-pharmaceutical interventions, and that it was expanding reliable access to GPT-Rosalind for select U.S. government and allied partners with public health and biodefense missions.

OpenAI named Fourth Eon Biosecurity, Lawrence Livermore National Laboratory, Johns Hopkins Applied Physics Laboratory, and the Coalition for Epidemic Preparedness Innovations among the first organizations it supported through the program.

Independent structure within a national initiative

According to the announcement, the AIBL will operate as an independent, non-profit organization designed to establish the UK as a world leader in AI-based biosecurity. The government said that, similar to the AI ​​Security Institute, the lab will attract leading technical talent from industry and academia and operate with enough autonomy to move with the speed and focus of a frontier AI-bio company.

The lab was launched as part of a national AI biosafety initiative bringing together the UK Health Security Agency, the Animal and Plant Health Agency and the Defense Science and Technology Laboratory with AIBL and the life sciences sector. The announcement states that the lab will maintain strong and trusted partnerships with government agencies and will also work with the Medicines and Healthcare products Regulatory Agency to prepare for health emergencies and inform the regulation of AI-designed medicines.

A scientific advisory board drawing on expertise from academia, industry and the third sector will support the laboratory. The government said further details of the scientific advisory board will be finalized in due course.